Cite
Monoclonal antibodies to the human mammary gland: III. Monoclonal antibody LICR-LON-M18 identifies impaired expression and excess sialylation of the I(Ma) cell-surface antigen by primary breast carcinoma cells.
MLA
Foster, C. S., and A. M. Neville. “Monoclonal Antibodies to the Human Mammary Gland: III. Monoclonal Antibody LICR-LON-M18 Identifies Impaired Expression and Excess Sialylation of the I(Ma) Cell-Surface Antigen by Primary Breast Carcinoma Cells.” Human Pathology, vol. 15, no. 6, June 1984, pp. 502–13. EBSCOhost, https://doi.org/10.1016/s0046-8177(84)80003-9.
APA
Foster, C. S., & Neville, A. M. (1984). Monoclonal antibodies to the human mammary gland: III. Monoclonal antibody LICR-LON-M18 identifies impaired expression and excess sialylation of the I(Ma) cell-surface antigen by primary breast carcinoma cells. Human Pathology, 15(6), 502–513. https://doi.org/10.1016/s0046-8177(84)80003-9
Chicago
Foster, C S, and A M Neville. 1984. “Monoclonal Antibodies to the Human Mammary Gland: III. Monoclonal Antibody LICR-LON-M18 Identifies Impaired Expression and Excess Sialylation of the I(Ma) Cell-Surface Antigen by Primary Breast Carcinoma Cells.” Human Pathology 15 (6): 502–13. doi:10.1016/s0046-8177(84)80003-9.